Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6345)
All Articles published online
|
Publishing Process of This Article
|
Jul 7, 2014 (publication date) through Dec 20, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kwon JE, Koh SJ, Chun J, Kim JW, Kim BG, Lee KL, Im JP, Kim JS, Jung HC. Effect of gastric acid suppressants and prokinetics on peritoneal dialysis-related peritonitis. World J Gastroenterol 2014; 20(25): 8187-8194 [PMID: 25057226 DOI: 10.3748/wjg.v20.i25.8187] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i25/8187.htm |
| Number | Citing Articles |
| 1 |
Karin Sandoval, Ken Witt. A worldwide yearly survey of new data in adverse drug reactions. Side Effects of Drugs Annual 2015; 37: 433 doi: 10.1016/bs.seda.2015.05.008
|
| 2 |
Lili Yao, Linfeng Ni, Xu Wu. Does the Use of Gastric‐Acid Suppressants Increase the Risk of Peritonitis in Patients Undergoing Peritoneal Dialysis? A Meta‐Analysis. Seminars in Dialysis 2024; 37(6): 424 doi: 10.1111/sdi.13226
|
| 3 |
Shira Goldman, Junhui Zhao, Brian Bieber, Ronald L. Pisoni, Laura Horowitz, Sharon J. Nessim, Beth Piraino, Mark Lambie, Talerngsak Kanjanabuch, Yasuhiko Ito, Neil Boudville, Isaac Teitelbaum, Martin Schreiber, Jeffrey Perl. Gastric Acid Suppression Therapy and Its Association with Peritoneal Dialysis–Associated Peritonitis in the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS). Kidney360 2024; 5(3): 370 doi: 10.34067/KID.0000000000000325
|
| 4 |
Hao-Jie Zhong, Da Lin, Zhi-Yong Lu, Wan-Ying Yang, Yu Chen. Use of gastric-acid suppressants may be a risk factor for enteric peritonitis in patients undergoing peritoneal dialysis: A meta-analysis. Journal of Clinical Pharmacy and Therapeutics 2019; 44(2): 209 doi: 10.1111/jcpt.12769
|
| 5 |
Sayaka Maeda, Makoto Yamaguchi, Kunihiro Maeda, Naoto Kobayashi, Naoki Izumi, Masaaki Nagai, Takaaki Obayashi, Wataru Ohashi, Takayuki Katsuno, Hironobu Nobata, Yasuhiko Ito, Hideharu Abe. Proton pump inhibitor use increases the risk of peritonitis in peritoneal dialysis patients. PLOS ONE 2019; 14(11): e0224859 doi: 10.1371/journal.pone.0224859
|
| 6 |
Yujing Zhang, Jiao Li, Zijun Chen, Lingling Liu, Xiaojiang Zhan, Fenfen Peng, Qian Zhou, Xianfeng Wu, Yingsi Zeng, Liya Zhu, Yuxin Xie, Xiaochun Lai, Zebin Wang, Yueqiang Wen, Xiaoran Feng, Jianbo Liang. Proton pump inhibitor usage associates with higher risk of first episodes of pneumonia and peritonitis in peritoneal dialysis patients. Renal Failure 2022; 44(1): 1624 doi: 10.1080/0886022X.2022.2129064
|
| 7 |
Nirbaanjot Walia, Nisha Rao, Michael Garrett, Karen Yates, Sarah Malone, Christian Holmes. Proton‐pump inhibitor use and the risk of peritoneal dialysis associated peritonitis. Internal Medicine Journal 2023; 53(3): 397 doi: 10.1111/imj.15601
|
| 8 |
Miguel Pérez-Fontan, Daniela Machado Lopes, Alba García Enríquez, Beatriz López-Calviño, Andrés López-Muñiz, Teresa García Falcón, Ana Rodríguez-Carmona, Abelardo I Aguilera. Inhibition of Gastric Acid Secretion by H2 Receptor Antagonists Associates a Definite Risk of Enteric Peritonitis and Infectious Mortality in Patients Treated with Peritoneal Dialysis. PLOS ONE 2016; 11(2): e0148806 doi: 10.1371/journal.pone.0148806
|